Ocular adverse event
|
Eye irritation | 19 (5.4) | 7 (6.1) |
Cataract/lens opacity | 10 (2.8) | 5 (4.3) |
Conjunctivitis/blepharitis | 10 (2.8) | 4 (3.5) |
Hyperaemia | 8 (2.3) | 3 (2.6) |
Visual field defect | 7 (2.0) | 10 (8.7) |
Vision decreased/blurred | 6 (1.7) | 4 (3.5) |
Corneal disorder | 4 (1.1) | - |
Conjunctival disorder | 1 (0.3) | 2 (1.7) |
Systemic adverse event
| | |
Infection, various | 8 (2.3) | 2 (1.7) |
Arthritis/muscle pain | 7 (2.0) | - |
Gastrointestinal symptoms | 6 (1.7) | 3 (2.6) |
Headache | 5 (1.4) | - |
Insomnia | 4 (1.1) | - |
Skin/hair disorder | 3 (0.9) | 3 (2.6) |
Trauma* | 4 (1.1) | 1 (0.9) |
Aggravated hypertension | 3 (0.9) | - |